Centene Corp (CNC)

Currency in USD
67.47
+1.43(+2.17%)
Closed·
67.65+0.18(+0.27%)
·
CNC is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
65.8567.61
52 wk Range
28.2469.36
Key Statistics
Prev. Close
66.04
Open
66.17
Day's Range
65.85-67.61
52 wk Range
28.24-69.36
Volume
2.27M
Average Volume (3m)
4.97M
1-Year Change
136.8199%
Book Value / Share
45.69
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
71.67
Upside
+6.22%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Centene Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

9 Buy
11 Hold
1 Sell
Ratings:
21 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 71.67
(+6.22% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Argus
Buy80.00+18.57%-UpgradeAug 11, 2026
JPMorgan
Hold67.00-0.70%60.00MaintainAug 04, 2026
Bernstein SocGen Group
Buy79.00+17.09%68.00MaintainAug 03, 2026
UBS
Hold70.00+3.75%61.00MaintainJul 29, 2026
Morgan Stanley
Hold66.00-2.18%57.00MaintainJul 29, 2026

Centene Corp SWOT Analysis


Enrollment Decline
Centene faces a projected 6% Medicaid enrollment decline through 2026, with mid-4% attrition rates challenging the company's core business model and scale advantages
Medicare Strategy
The company pursues break-even status in Medicare Advantage amid prescription drug plan margin pressures creating a $0.74 negative earnings impact
Analyst Outlook
Cantor Fitzgerald maintains a Neutral rating with a $41 price target, reflecting cautious sentiment amid membership losses and profitability challenges
Market Position
Despite near-term headwinds, Centene's Medicaid expertise and government program relationships position the company to capitalize on demographic trends and potential enrollment stabilization
Read full SWOT analysis

Centene Corp Earnings Call Summary for Q2/2026

  • Centene reported Q2 2026 adjusted EPS of $2.51, beating estimates by $1.44, but shares fell 8.15% as $0.50 came from non-recurring settlements.
  • Revenue reached $53.58B, exceeding forecasts by $6B; full-year EPS guidance raised to over $4.80 from $3.40, though includes one-time gains.
  • Health benefit ratio improved 340bps to 89.6% YoY; operating cash flow hit $8.0B YTD while debt-to-capital fell to 41.6% from 46.5%.
  • Medicaid membership expected to decline 8-9% in 2026, worse than prior 6% forecast; Q3 to be slightly above breakeven, Q4 expected loss.
  • Medicare Part D margins raised to over 3% from 2%; Marketplace margins increased to 4.5-5% from 3%; Medicare Advantage nearing breakeven for 2026.
Last Updated: 2026-07-28, 09:54 a/m
Read Full Transcript

Earnings

Latest Release
Jul 28, 2026
EPS / Forecast
2.51 / 1.07
Revenue / Forecast
53.58B / 47.63B
EPS Revisions
Last 90 days

CNC Income Statement

Compare CNC to Peers and Sector

Metrics to compare
CNC
Peers
Sector
Relationship
P/E Ratio
−6.5x26.8x−0.4x
PEG Ratio
0.02−0.070.00
Price/Book
1.5x5.0x2.6x
Price / LTM Sales
0.2x0.8x3.1x
Upside (Analyst Target)
4.5%17.0%48.3%
Fair Value Upside
Unlock16.6%6.2%Unlock

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
218.22M44.17%14.72B
Other Institutional Investors
282.41M55.83%19.05B
Public Companies & Retail Investors
0.000.00%0.00
Total
500.63M100.00%33.78B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.39%41,446,0462,796,365
Vanguard Capital Management, LLC6.86%33,886,4312,286,317

People Also Watch

313.82
COR
+1.23%
235.17
CAH
+1.70%
181.09
IT
-1.21%
58.79
CTSH
-0.84%
331.71
ONTO
-1.81%

FAQ

What Is the Centene (CNC) Stock Price Today?

The Centene stock price today is 67.47 USD.

What Stock Exchange Does Centene Trade On?

Centene is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Centene?

The stock symbol for Centene is "CNC."

What Is the Centene Market Cap?

As of today, Centene market cap is 33.33B USD.

What Is Centene's Earnings Per Share (TTM)?

The Centene EPS (TTM) is -10.36.

When Is the Next Centene Earnings Date?

Centene will release its next earnings report on Oct 27, 2026.

From a Technical Analysis Perspective, Is CNC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Centene Stock Split?

Centene has split 4 times.

How Many Employees Does Centene Have?

Centene has 61100 employees.

What is the current trading status of Centene (CNC)?

As of Aug 16, 2026, Centene (CNC) is trading at a price of 67.47 USD, with a previous close of 66.04 USD. The stock has fluctuated within a day range of 65.85 USD to 67.61 USD, while its 52-week range spans from 28.24 USD to 69.36 USD.

What Is Centene (CNC) Price Target According to Analysts?

The average 12-month price target for Centene is 71.67 USD, with a high estimate of 85 USD and a low estimate of 56 USD. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +6.22% Upside potential.

What Is the CNC Premarket Price?

CNC's last pre-market stock price is 66.10 USD. The pre-market share volume is 2,110.00, and the stock has decreased by 0.06, or 0.09%.

What Is the CNC After Hours Price?

CNC's last after hours stock price is 67.65 USD, the stock has decreased by 0.18, or 0.27%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.